NATIONAL BUREAU OF ECONOMIC RESEARCH
NATIONAL BUREAU OF ECONOMIC RESEARCH

Reference Pricing of Pharmaceuticals for Medicare: Evidence from Germany, the Netherlands, and New Zealand

Patricia M. Danzon, Jonathan D. Ketcham

Chapter in NBER book Frontiers in Health Policy Research, Volume 7 (2004), David M. Cutler and Alan M. Garber, editors (p. 1 - 54)
Conference held June 6, 2003
Published in July 2004 by MIT Press
in NBER Book Series Frontiers in Health Policy Research

download in pdf format
   (453 K)

email paper

This paper is available as PDF (453 K) or via email.

Machine-readable bibliographic record - MARC, RIS, BibTeX

This chapter first appeared as NBER working paper w10007, Reference Pricing of Pharmaceuticals for Medicare: Evidence from Germany, the Netherlands and New Zealand, Patricia M. Danzon, Jonathan D. Ketcham
Users who downloaded this chapter also downloaded these:
Danzon and Ketcham w10007 Reference Pricing of Pharmaceuticals for Medicare: Evidence from Germany, the Netherlands and New Zealand
Golec and Vernon w12676 European Pharmaceutical Price Regulation, Firm Profitability, and R&D Spending
Danzon and Epstein w14041 Effects of Regulation on Drug Launch and Pricing in Interdependent Markets
Danzon and Percy The Effects of Price Regulation on Productivity in Pharmaceuticals
Danzon and Keuffel Regulation of the Pharmaceutical-Biotechnology Industry
 
Publications
Activities
Meetings
NBER Videos
Data
People
About

Support
National Bureau of Economic Research, 1050 Massachusetts Ave., Cambridge, MA 02138; 617-868-3900; email: info@nber.org

Contact Us